{"organizations": ["CSA Medical, Inc.", "USP", "Sagent Pharmaceuticals, Inc."], "uuid": "e629d946f56bc44cd2a71cd1c02479fa21f465a2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Duchenne-Muscular-Dystrophy-Drugs-Market-2015-2019-47962-1/", "country": "US", "title": "Global Duchenne Muscular Dystrophy Drugs Market 2015-2019", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Global Duchenne Muscular Dystrophy Drugs Market 2015-2019", "spam_score": 0.0, "site_type": "news", "published": "2015-09-02T17:04:00.000+03:00", "replies_count": 0, "uuid": "e629d946f56bc44cd2a71cd1c02479fa21f465a2"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Duchenne-Muscular-Dystrophy-Drugs-Market-2015-2019-47962-1/", "ord_in_thread": 0, "title": "Global Duchenne Muscular Dystrophy Drugs Market 2015-2019", "locations": ["Fla.", "U.S.", "UK", "London"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Bill", "William H. Floyd President", "Cartledge"], "text": "  -- Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ) has ... to Medical Device Software: Regulations and Requirements (London, ... their offering. This course will ... requirements that apply to Medical Device Software. The ... examples and state-of- the-art practices identified from Notified   -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... \"Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of   BOCA RATON, Fla. , Sept. 2, 2015 ... Cartledge , MD, FACS, has begun performing ultra-minimally ... patients who are on anticoagulants such as Coumadin, ... of Cardiothoracic Surgery at the Hospital, is one ... this method, which involves making two microscopic incisions ... [ 0 ] An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 [ 0 ] Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 [ 0 ] Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients ... 2, 2010 CSA Medical, Inc. ( www.CSAmedical.com ) ... incoming president, CEO and member of the board of ... years of medical device experience, including market development roles ... \"We are thrilled to have Bill join ... ... Dec. 2, 2010 Sagent Pharmaceuticals, Inc., a ... approval of four presentations of midazolam injection, USP, ... which will be offered in latex-free vials, in ... U.S. market for injectable midazolam approximated $52 million. ... CSA Medical Appoints William H. Floyd President and CEO Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP  ", "external_links": [], "published": "2015-09-02T17:04:00.000+03:00", "crawled": "2015-09-03T10:29:28.598+03:00", "highlightTitle": ""}